Therapeutic effect of r-SK on acute myocardial infarction: a report of 20 cases
- VernacularTitle:基因重组链激酶治疗急性心肌梗死20例疗效观察
- Author:
Changyong BIAN
;
Yongwen QIN
;
Xing ZHENG
- Publication Type:Journal Article
- Keywords:
myocardial infarction;
streptokinase,recombinant;
thrombolytic therapy
- From:
Academic Journal of Second Military Medical University
1999;0(12):-
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To observe the therapeutic effect of intravenous thrombolysis of recombinant streptokinase (r SK) on acute myocardial infarction (AMI) and its safety. Methods: Twenty patients with AMI received r SK for thrombolysis.The reopening rate of infarct related artery,side effect and the fatality rate in hospital were observed. Results: The reopening rate of infarct related artery was 75%. The incidence of slight hemorrhage, fever, low blood pressure,which could be corrected in short time, was 5%, 15%, 15%, respectively. The fatality rate 5 weeks after AMI was 10%. Conclusion: The therapeutic effect of r SK in the thrombolytic therapy of AMI is definite and the safety is fine.
